Trial intelligence / Profile preview

PAPABEAR: Prophylactic Amiodarone for Post-Op Arrhythmias

NCT00251706Phase 3Completed

Sponsor
University of Calgary
Start
Feb 1999
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Amiodarone with Placebo (2 arms). Primary endpoints: Incidence of post-operative atrial tachyarrhythmia (>5 minutes), Ventricular response rate of atrial tachyarrhythmias and 2 more. Started Feb 1999; status: completed.

02

Drugs

amiodarone
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00251706.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00251706.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call